GE HealthCare reported a 5.8% increase in total revenues for the second quarter, reaching $5.3 billion. The medical-technology company attributed this growth to healthy demand and a significant rise in orders, which were up 11% during the quarter. This performance exceeded the company's expectations for mid-single-digit order growth.

Chief Executive Peter Arduini highlighted strong commercial execution and the successful adoption of new products as key drivers. He noted order growth across all segments, with particular strength observed in longer-cycle products within radiology.

The company's profit also saw an increase, surpassing analyst expectations. The robust performance indicates a positive trend for GE HealthCare amidst a period of healthy demand for its medical technologies.